Exosome research products find diverse applications in biomedical research. These products are utilized for the isolation, analysis, and characterization of exosomes, enabling researchers to study their functions, cargo, and potential therapeutic applications. Key features of exosome research products include specialized isolation kits, purification reagents, and analysis tools, designed to efficiently extract and analyze exosomes. They facilitate the investigation of exosome-based biomarkers, drug delivery systems, and regenerative medicine. Exosome research products are invaluable for understanding intercellular communication, and disease mechanisms, and developing innovative diagnostic and therapeutic approaches in fields such as oncology, neurology, and regenerative medicine.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-exosome-research-products-market
Data Bridge Market Research analyses that the Global Exosome Research Products Market is valued at USD 195,264.00 thousand in 2022 and is expected to reach USD 2,232,028.31 thousand by 2030, registering a CAGR of 35.6% during the forecast period of 2023 to 2030. Exosomes, as a type of extracellular vesicles, have gained significant attention in the scientific community due to their role in intercellular communication and their potential as biomarkers and therapeutic agents, thus boosting the market’s growth.
Key Findings of the Study
Advancements in isolation and characterization techniques is expected to drive the market's growth rate
The demand for exosome isolation kits, reagents, and analysis tools has increased due to continuous advancements in isolation and characterization techniques. Techniques like ultracentrifugation, size-exclusion chromatography, and flow cytometry have undergone significant developments, making the study of exosomes easier and more efficient. These advancements have facilitated the isolation and characterization of exosomes, leading to increased interest and research in the field. As a result, there is a growing demand for specialized products and tools that enable researchers to effectively study and analyze exosomes.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Thousands, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Instruments and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnostics), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, and Direct Tender)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Hologic Inc. (U.S.), Luminex Corporation (U.S.), Thermo Fisher Scientific (U.S.), Agilent Technologies, Inc. (U.S.), RoosterBio, Inc. (U.S.), Microgentas (U.S.), Cell Guidance Systems LLC (U.S.), QIAGEN (Netherlands), FUJIFILM Irvine Scientific (a subsidiary of FUJIFILM Holdings Corporation) (U.S.), CUSABIO TECHNOLOGY LLC (U.S.), NEXOSOME-ONCOLOGY (U.S.), Norgen Biotek Corp. (Canada), Miltenyi Biotec (Germany), Aethlon Medical, Inc. (U.S.), System Biosciences, LLC. (U.S.), AMSBIO (U.K.), ExoDx (Acquired By Bio-Techne) (U.S.), BioVision Inc. (Acquired By Abcam plc) (U.S.), HBMLS (Acquired by Lonza) (Switzerland), Creative Bioarray (U.S.), NanoSomiX (U.S.), Novus Biologicals (U.S.), Beckman Coulter, Inc. (U.S.), JSR Micro NV (Japan), Hitachi, Ltd. (Japan), INOVIQ (U.S.), ProteoGenex (U.S.), and Audubon Bioscience (U.S.).
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The exosome research products market is segmented on the basis of product, indication, application, end user, and distribution channel.
- On the basis of product, the global exosome research products market is segmented into instruments and consumables. In 2023, consumables segment is expected to dominate the market growing at the highest CAGR of 36.6% in the forecast period of 2023 to 2030 due to its essential role in various research applications.
In 2023, the consumables segment is dominating the products segment of the global exosome research products market
In 2023, the consumables segment is dominating the market growing at the highest CAGR of 36.6% in the forecast period of 2023 to 2030 as consumables refer to the reagents, kits, and other disposable items required for isolating, purifying, analyzing, and characterizing exosomes. As exosome research continues to expand, there is a growing demand for high-quality consumables that offer reliable and reproducible results. Researchers heavily rely on consumables for sample preparation, RNA or protein extraction, isolation methods, and detection assays.
- On the basis of indication, the global exosome research products market is segmented into cancer and non-cancer. In 2023, the cancer segment is expected to dominate the market growing at the highest CAGR of 36.2% in the forecast period of 2023 to 2030 due to the significant role of exosomes in cancer research and diagnostics.
In 2023, the cancer segment is dominating the indication of the global exosome research products market
In 2023 cancer segment is dominating the indication segment of the global exosome research products market growing at the highest CAGR of 36.2% in the forecast period of 2023 to 2030 as exosomes derived from cancer cells contain unique biomarkers and genetic material, making them valuable tools for cancer detection, monitoring, and treatment response assessment. Researchers extensively study cancer-derived exosomes to understand tumor biology, identify new biomarkers, and develop targeted therapies.
- On the basis of application, the global exosome research products market is segmented into therapeutics and diagnostics. In 2023, the therapeutics segment is expected to dominate the market growing at the highest CAGR of 36.9% in the forecast period of 2022 to 2029 due to the growing interest in utilizing exosomes as therapeutic agents.
- On the basis of end users, the global exosome research products market is segmented into hospitals, clinical testing laboratory, research centers, pharmaceutical and biotechnology company, academic institutes, and others. The pharmaceutical and biotechnology company segment dominates the market during the forecast period 2023 to 2030 at CAGR 38.5% due to the extensive use of exosomes in drug discovery and development, as well as in biotechnological applications.
- On the basis of distribution channel, the global exosome research products market is segmented into third party distributors, online, and direct tender. The third party distributors segment dominates the market during the forecast period 2023 to 2030 at CAGR 37.2% as these manufacturers and suppliers play a pivotal role in developing and providing a wide range of products and solutions for exosome research, including isolation kits, purification reagents, analysis tools, and other related consumables.
Major Players
Data Bridge Market Research recognizes the following companies as the major exosome research products market players in exosome research products market are Hologic Inc. (U.S.), Luminex Corporation (U.S.), Thermo Fisher Scientific (U.S.), Agilent Technologies, Inc. (U.S.), RoosterBio, Inc. (U.S.), Microgentas (U.S.)
Market Development
- In July 2022, Aethlon Medical, Inc., a company specializing in medical therapies for cancer and life-threatening infectious diseases, recently announced the approval of a protocol amendment by the U.S. Food and Drug Administration (FDA).
- ExoDX has recently introduced the ExoDX Prostate Test Home Collection Kit, catering to patients who have concerns about prostate health. This innovative kit offers a convenient and cost-effective solution, allowing patients to collect samples from the comfort of their homes.
Regional Analysis
Geographically, the countries covered in the exosome research products market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the exosome research products market during the forecast period 2023 - 2030
In 2023, North America dominated the exosome research products market owing to the development of cutting-edge technologies, such as next-generation sequencing, mass spectrometry, and high-resolution imaging, which has revolutionized the field of exosome research. These advanced techniques have enhanced our understanding of exosomes, including their biogenesis, cargo, and functional roles. Moreover, they have enabled more accurate and sensitive detection, isolation, and characterization of exosomes.
Asia-Pacific is estimated to be the fastest-growing region in the exosome research products market in the forecast period 2023 - 2030
Asia-Pacific is expected to grow during the forecast period as strong market presence, global reach, and established customer base have contributed to the overall growth of the exosome research products market. Furthermore, their continuous efforts in innovation, product development, and strategic collaborations have fueled the demand for exosome research products and propelled advancements in the field of exosome research.
For more detailed information about the exosome research products market report, click here – https://www.databridgemarketresearch.com/reports/global-exosome-research-products-market
